Literature DB >> 21927039

Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT.

C Calmettes, S Vigouroux, R Tabrizi, N Milpied.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21927039     DOI： 10.1038/bmt.2011.179

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation.

Authors:  Limei Michelle Poon; Antonio Di Stasi; Uday Popat; Richard E Champlin; Stefan O Ciurea
Journal:  Am J Blood Res       Date:  2013-08-19

2.  Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children.

Authors:  Natalia Maximova; D Zanon; F Rovere; A Maestro; G Schillani; R Paparazzo
Journal:  Int J Hematol       Date:  2015-06-18       Impact factor: 2.490

Review 3.  Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Leyre Bento; Mariana Canaro; José María Bastida; Antonia Sampol
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

4.  Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature.

Authors:  Marta Bortolotti; Loredana Pettine; Anna Zaninoni; Giorgio Alberto Croci; Wilma Barcellini; Bruno Fattizzo
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.